Literature DB >> 15473140

Assessment of areas at increased risk for poliovirus circulation in Ecuador.

Gustavo H Dayan1, Rodrigo Rodríguez, Jan Vinjé, Nancy Vásconez, Víctor Cáceres, Nicole Gregoricus, Mark Sobsey, Mauricio Landaverde.   

Abstract

To assess areas at risk for poliovirus circulation in Ecuador, we first selected provinces at highest risk based on low immunization coverage with three doses of oral poliovirus vaccine, and a low number of reported cases of acute flaccid paralysis (AFP). Subsequently, we reviewed discharge data for the period 1996--2000 for diagnoses compatible with AFP in the only two national referral hospitals in Quito, and at least two main hospitals in each of the six selected provinces. Environmental samples from one or two cities/towns in each selected province were tested for poliovirus. Of the 14 identified AFP-compatible cases, 8 (57%) had been previously reported and investigated. We visited four out of the six unreported cases; none of those four had sequelae compatible with poliomyelitis. From the 14 environmental samples taken, we identified Sabin viruses in six of the samples; no vaccine-derived polioviruses were isolated. Using this methodology, we found no evidence of undetected poliovirus circulation in Ecuador.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15473140      PMCID: PMC2870164          DOI: 10.1017/s0950268804002626

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  2 in total

Review 1.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

Review 2.  A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus.

Authors:  Graciela Matrajt; Brienna Naughton; Ananda S Bandyopadhyay; John Scott Meschke
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.